Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. SPY
6. MRK
7. HD
8. DVLT
9. PGR
10. EPM

Go back to Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
(NASDAQ: ANIX) Delayed: 3.71 +0.28 (8.16%)
Previous Close $3.43    52 Week High $ 
Open $3.49    52 Week Low $ 
Day High $3.81    P/E N/A 
Day Low $3.46    EPS $ 
Volume 569,587